IL6 and ovarian carcinoma: Furthermore, we screened the IL-6 inhibitory compounds using an in vitro cytotoxicity test against the ovarian cancer cell lines (A2780/SKOV3) and drug-resistant variants (A2780-Cis/SKOV3-TR) to assess their anticancer potential.